Trial Profile
Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver Transplantation: A Randomized Controlled Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2023
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Acute kidney injury
- Focus Therapeutic Use
- 13 Jul 2023 Planned End Date changed from 31 Dec 2024 to 7 Jul 2024.
- 13 Jul 2023 Status changed from recruiting to active, no longer recruiting.
- 15 May 2023 Planned number of patients changed from 134 to 214.